Search Share Prices
AZN Shares - AstraZeneca’s (AZN) Hold Rating Reaffirmed at Liberum Capital
Liberum Capital reiterated their hold rating on shares of AstraZeneca (LON:AZN) in a research note released on Tuesday morning. A number of other research firms have also weighed in on AZN. JPMorgan C...
AstraZeneca share price: Group strengthens partnership with Innate Pharma
AstraZeneca (LON:AZN) has moved to strengthen its position in the immuno-oncology field, expanding its collaboration with French biotech company Innate Pharma, the Anglo-Swedish group has said.
FTSE 100 boosted by weak pound; US stocks seen opening on the front foot
9.50am: AstraZeneca’s Lynparza cancer drug excels in late-stage study Results from a late-stage trial of AstraZeneca PLC’s (LON:AZN) Lynparza drug show that it could be an important cancer treatment. ...
AstraZeneca share price: Group posts upbeat results from Lynparza trial
A late-stage trial has showed that AstraZeneca’s (LON:AZN) oncology treatment Lynparza cut risk of disease progression or death by 70 percent in patients with newly-diagnosed, advanced BRCA ...
AstraZeneca reveals trial of Lynparza drug reduces risk of ovarian cancer worsening
AstraZeneca PLC (LON:AZN) said a phase III trial of its Lynparza drug greatly showed to greatly reduce the risk of ovarian cancer worsening. Lynparza halted or reversed tumour growth in 60% of patient...